» Articles » PMID: 24669209

Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala

Overview
Date 2014 Mar 27
PMID 24669209
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The autistic spectrum disorders (ASD) form a set of multi-faceted disorders with significant genetic, epigenetic and environmental determinants. Oxidative and nitrosative stress (O&NS), immuno-inflammatory pathways, mitochondrial dysfunction and dysregulation of the tryptophan catabolite (TRYCATs) pathway play significant interactive roles in driving the early developmental etiology and course of ASD. O&NS interactions with immuno-inflammatory pathways mediate their effects centrally via the regulation of astrocyte and microglia responses, including regional variations in TRYCATs produced. Here we review the nature of these interactions and propose an early developmental model whereby different ASD genetic susceptibilities interact with environmental and epigenetic processes, resulting in glia biasing the patterning of central interarea interactions. A role for decreased local melatonin and N-acetylserotonin production by immune and glia cells may be a significant treatment target.

Citing Articles

Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders.

Savino R, Polito A, Marsala G, Ventriglio A, Di Salvatore M, de Stefano M Brain Sci. 2023; 13(5).

PMID: 37239206 PMC: 10216109. DOI: 10.3390/brainsci13050734.


Multivariate Analysis of Metabolomic and Nutritional Profiles among Children with Autism Spectrum Disorder.

Qureshi F, Adams J, Audhya T, Hahn J J Pers Med. 2022; 12(6).

PMID: 35743708 PMC: 9224818. DOI: 10.3390/jpm12060923.


Potential crosstalk between sonic hedgehog-WNT signaling and neurovascular molecules: Implications for blood-brain barrier integrity in autism spectrum disorder.

Gozal E, Jagadapillai R, Cai J, Barnes G J Neurochem. 2021; 159(1):15-28.

PMID: 34169527 PMC: 8484047. DOI: 10.1111/jnc.15460.


Analyzing the Potential Biological Determinants of Autism Spectrum Disorder: From Neuroinflammation to the Kynurenine Pathway.

Savino R, Carotenuto M, Polito A, Di Noia S, Albenzio M, Scarinci A Brain Sci. 2020; 10(9).

PMID: 32932826 PMC: 7563403. DOI: 10.3390/brainsci10090631.


Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians.

Saggese G, Vierucci F, Prodam F, Cardinale F, Cetin I, Chiappini E Ital J Pediatr. 2018; 44(1):51.

PMID: 29739471 PMC: 5941617. DOI: 10.1186/s13052-018-0488-7.


References
1.
Sajdel-Sulkowska E, Xu M, McGinnis W, Koibuchi N . Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). Cerebellum. 2010; 10(1):43-8. DOI: 10.1007/s12311-010-0223-4. View

2.
ORoak B, Vives L, Girirajan S, Karakoc E, Krumm N, Coe B . Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012; 485(7397):246-50. PMC: 3350576. DOI: 10.1038/nature10989. View

3.
Gabriels R, Agnew J, Pan Z, Holt K, Reynolds A, Laudenslager M . Elevated repetitive behaviors are associated with lower diurnal salivary cortisol levels in autism spectrum disorder. Biol Psychol. 2013; 93(2):262-8. DOI: 10.1016/j.biopsycho.2013.02.017. View

4.
Jyonouchi H, Sun S, Le H . Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol. 2001; 120(1-2):170-9. DOI: 10.1016/s0165-5728(01)00421-0. View

5.
Sweeten T, Posey D, Shankar S, McDougle C . High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry. 2004; 55(4):434-7. DOI: 10.1016/j.biopsych.2003.09.001. View